Sign in

Harv Virk

@harv-virk.bsky.social
55 followers 85 following 11 posts

OGA community, YCharOS UK, UK Reproducibilty Network, University of Leicester. Respiratory Medicine. NIHR ACL MRC New Investigator

PostsRepliesMedia
Reposted by Harv Virk
Johan Duchêne @johanduchene.bsky.social · 26/08/2026
Wow! Only Good Antibodies has developed a new tool that lets you see, directly in a paper, which antibodies were tested and validated. A tool that comes at the right time, given all the issues surrounding antibody validation. Definitively a tool to get onlygoodantibodies.co.uk/extension/
onlygoodantibodies.co.uk
Browser Extension — Only Good Antibodies
A free browser extension that marks antibodies cited in a paper with their knockout-controlled validation status, for the application they were used in.
13715
Reposted by Harv Virk
Only Good Antibodies Community @oga-community.bsky.social · 10/06/2026
Meet Abigail Parsons, one of our Antibody Champions. Abi joins a UK wide network helping their institutions make better antibody choices through local workshops and free tools built by OGA onlygoodantibodies.co.uk/champions/ #BrainCancer #3Rs #AntibodyValidation #ReproducibleResearch #OpenScience
062
Harv Virk @harv-virk.bsky.social · 09/03/2026
[1/6] Two new preprints out today from the OGA team. We've quantified the ethical costs of poor antibody validation for the first time — and developed a consensus plan to fix it. Thread 🧵
221
Harv Virk @harv-virk.bsky.social · 06/02/2026
000
Reposted by Harv Virk
Center for Open Science @cos.io · 01/04/2025
In Lifecycle Journal's publish-before-review model, research is published before undergoing evaluation. Published submissions are eligible for review by services including @oga-community.bsky.social, a nonprofit that evaluates research that relies on antibodies: lifecyclejournal.org/evaluation-s...
lifecyclejournal.org
Lifecycle Journal | Adding trust to your research, from conception through completion
074
Reposted by Harv Virk
UK Reproducibility Network @ukrepro.bsky.social · 28/03/2025
We're very pleased to publicly announce the winners of the 2025 Dorothy Bishop Prize, which celebrates the contributions of early career researchers working to promote #OpenResearch and improve #ResearchCulture. Congratulations to: - Annayah Prosser - Michael Biddle - Lewis Jones #AcademicSky
ukrn.org
Dorothy Bishop Prize Winners 2025 | UK Reproducibility Network
1114
Reposted by Harv Virk
Only Good Antibodies Community @oga-community.bsky.social · 21/03/2025
Congratulations Michael Biddle for winning the @ukrepro.bsky.social Dorothy Bishop award for your contributions to #Open and #Reproducible research culture. We are so proud of all of the excellent work you have been leading!
032
Reposted by Harv Virk
Only Good Antibodies Community @oga-community.bsky.social · 04/03/2025
Congratulations Michael Biddle for your nomination for this award recognising contributions to #Open , #Reproducible , and generally better research! www.ukrn.org/2025/03/04/d...
ukrn.org
DB Prize 2025 shortlisted nominees
031
Reposted by Harv Virk
eLife @elife.bsky.social · 04/02/2025
We’re pleased to join the UK Reproducibility Network (@ukrepro.bsky.social) as a stakeholder in support of a more open, transparent and reproducible research culture. Find out more:
ukrn.org
UKRN welcomes eLife and Hidden REF as new stakeholders | UK Reproducibility Network
Feb 4, 2025 | News
0156
Reposted by Harv Virk
Nikolai Slavov @slavov-n.bsky.social · 31/01/2025
This rate of validation suggests that antibodies should be considered non-specific until proven otherwise: 357 validated out of 1,124 tested. .
44314
Harv Virk @harv-virk.bsky.social · 28/01/2025
www.ukrn.org/2025/01/28/u...
001
Reposted by Harv Virk
MRC AIM DTP @mrcaimdtp.bsky.social · 09/01/2025
🚨 Just over 24 hours left for PhD applications to be submitted to join our DTP 📅 Midday (GMT) TOMORROW Friday 10 Jan The application form and all details are on our website more.bham.ac.uk/mrc-aim/phd-... as well as a helpful FAQ doc and two Zoom recordings from recently held information sessions
111
Reposted by Harv Virk
Addgene @addgene.bsky.social · 20/12/2024
📣Check out "A Consensus Platform for Antibody Validation," which describes YCharOS's knockout cell-line based antibody validation platform. 📣 www.nature.com/artic...
nature.com
A consensus platform for antibody characterization
Nature Protocols - YCharOS is a consensus platform for antibody characterization developed through collaboration between academia and industry, enabling direct comparisons among antibodies that...
134
Reposted by Harv Virk
Only Good Antibodies Community @oga-community.bsky.social · 20/12/2024
Better antibodies, Better science, Better patient outcomes. Visit us to find out more! onlygoodantibodies.com/projects/
onlygoodantibodies.com
Our Projects - Only Good Antibodies Community
032
Reposted by Harv Virk
Only Good Antibodies Community @oga-community.bsky.social · 20/12/2024
Learn more about us and our collaboration with @ycharos.bsky.social in this @nature.com feature by Diana Kwon. www.nature.com/articles/d41...
nature.com
The antibodies don’t work! The race to rid labs of molecules that ruin experiments
Poorly performing antibodies have plagued biomedical sciences for decades. Several fresh initiatives hope to change this.
021
Harv Virk @harv-virk.bsky.social · 18/12/2024
leicesterbrc.nihr.ac.uk/harvinder-vi...
leicesterbrc.nihr.ac.uk
New protocol will drive a shared roadmap towards more reliable and cost-effective use of antibodies in biomedical research - NIHR Leicester Biomedical Research Centre
A blog by Dr Harvinder Virk - NIHR Academic Clinical Lecturer in Respiratory Medicine, MRC New Investigator (Early Career Researcher).
031
Reposted by Harv Virk
Aled Edwards S.G. @aledmedwards.bsky.social · 17/12/2024
The @ycharos.bsky.social antibody characterization protocol using knock-out cells as controls is now published, and endorsed. Remember though that it’s a generic protocol - you still need to do the proper controls for your own experiments! www.nature.com/articles/s41...
nature.com
YCharOS protocol for antibody validation - Nature Protocols
Poorly performing antibodies contribute to the reproducibility crisis in biomedical research. The market offers millions of antibodies and validating them is a cumbersome process. Now, the non-profit ...
053